Calciphylaxis in Patients With Preserved Kidney Function

Natallia Maroz MD, FASN, FACP , Samer Mohandes MD , Halle Field MD , Zlata Kabakov MD , Richard Simman MD, FACS, FACCWS
{"title":"Calciphylaxis in Patients With Preserved Kidney Function","authors":"Natallia Maroz MD, FASN, FACP ,&nbsp;Samer Mohandes MD ,&nbsp;Halle Field MD ,&nbsp;Zlata Kabakov MD ,&nbsp;Richard Simman MD, FACS, FACCWS","doi":"10.1016/j.jccw.2015.08.002","DOIUrl":null,"url":null,"abstract":"<div><p><span>Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a devastating disease typically seen </span>in patients<span><span> with end stage renal disease<span>. It manifests as extremely painful symmetrical wounds resistant to surgical and medical interventions. The prevalence of CUA among hemodialysis dependent patients was found to be as high as 4.1%. The management of patients with CUA requires a multidisciplinary approach by the medical team, yet often results in a low rate of successful outcomes. Recently, non-uremic calciphylaxis (NUC) has been described in the absence of </span></span>kidney disease. Limited knowledge exists on the management of NUC and the outcomes of this condition. Herein we describe three clinical scenarios of patients diagnosed with NUC in the absence of permanent or prolonged acute renal pathology. The reporting of successful and fruitless therapeutic interventions for wound management in NUC is important for compiling the evidence of effective therapeutic strategies.</span></p></div>","PeriodicalId":90358,"journal":{"name":"The journal of the American College of Clinical Wound Specialists","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jccw.2015.08.002","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of the American College of Clinical Wound Specialists","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213510315000494","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a devastating disease typically seen in patients with end stage renal disease. It manifests as extremely painful symmetrical wounds resistant to surgical and medical interventions. The prevalence of CUA among hemodialysis dependent patients was found to be as high as 4.1%. The management of patients with CUA requires a multidisciplinary approach by the medical team, yet often results in a low rate of successful outcomes. Recently, non-uremic calciphylaxis (NUC) has been described in the absence of kidney disease. Limited knowledge exists on the management of NUC and the outcomes of this condition. Herein we describe three clinical scenarios of patients diagnosed with NUC in the absence of permanent or prolonged acute renal pathology. The reporting of successful and fruitless therapeutic interventions for wound management in NUC is important for compiling the evidence of effective therapeutic strategies.

保留肾功能患者的钙化反应
钙化性尿毒症小动脉病(CUA),也称为钙化反应,是一种毁灭性疾病,通常见于终末期肾病患者。它表现为极度痛苦的对称伤口,对手术和医疗干预无效。血液透析依赖患者中CUA的患病率高达4.1%。CUA患者的管理需要医疗团队的多学科方法,但往往导致低成功率的结果。最近,非尿毒症性钙化反应(NUC)已被描述为没有肾脏疾病。关于NUC的管理和这种情况的结果的知识有限。在这里,我们描述了三种临床情况诊断为NUC的患者在没有永久性或长期急性肾脏病理。报告NUC伤口管理中成功和无效的治疗干预措施对于编制有效治疗策略的证据非常重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信